Michel Demeule
- Molecular Biology top 5%
- Oncology top 2%
- Biomaterials top 1%
- Pediatrics, Perinatology and Child Health top 2%
- Neurology top 2%
- Co-authors
- Richard BéliveauAnthony RéginaJulie JodoinDenis GingrasJean‐Paul CastaigneReinhard GabathulerChristian ChéYanick Bertrand
- Topics
- Drug Transport and Resistance Mechanisms (30 papers)Nanoparticle-Based Drug Delivery (12 papers)Ion Transport and Channel Regulation (11 papers)
- Cited by
- BiomaterialsOncologyNeurology
- Journals
- Journal of Biological ChemistryJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- CanadaFranceUnited States
In The Last Decade
Michel Demeule
84 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 124
- Molecular Biology 2.2k
- Oncology 1.7k
- Biomaterials 878
- Pediatrics, Perinatology and Child Health 443
- Neurology 432
Countries citing papers authored by Michel Demeule
This map shows the geographic impact of Michel Demeule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Demeule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Demeule more than expected).
Fields of papers citing papers by Michel Demeule
This network shows the impact of papers produced by Michel Demeule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Demeule. The network helps show where Michel Demeule may publish in the future.
Co-authorship network of co-authors of Michel Demeule
This figure shows the co-authorship network connecting the top 25 collaborators of Michel Demeule. A scholar is included among the top collaborators of Michel Demeule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Demeule. Michel Demeule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 14 | |
| 4 | 42 | |
| 5 | 88 | |
| 6 | 56 | |
| 7 | 54 | |
| 8 | 45 | |
| 9 | 14 | |
| 10 | 47 | |
| 11 | 28 | |
| 12 | 15 | |
| 13 | 177 | |
| 14 | 103 | |
| 15 | 75 | |
| 16 | 15 | |
| 17 | 33 | |
| 18 | 5 | |
| 19 | 25 | |
| 20 | 1 |
About Michel Demeule
Michel Demeule is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 87 papers that have together received 4.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (30 papers), Nanoparticle-Based Drug Delivery (12 papers) and Ion Transport and Channel Regulation (11 papers). The work is most often cited by research in Biomaterials (878 citations), Oncology (1.7k citations) and Neurology (432 citations). Michel Demeule has collaborated with scholars based in Canada, France and United States. Frequent co-authors include Richard Béliveau, Anthony Régina, Julie Jodoin, Denis Gingras, Jean‐Paul Castaigne, Reinhard Gabathuler, Christian Ché, Yanick Bertrand, Julie Poirier and Édith Beaulieu. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.